BACKGROUND: The adult human thymus contributes to de novo T cell synthesis; such synthesis can be assessed by analyzing T cell receptor excision circles (TREC). METHODS: TREC levels were measured in total peripheral blood mononuclear cells (PBMC) and CD4- and CD8-enriched cells of 29 HIV-positive patients with maximal viral suppression. The expression of CD45RA+CD45RO-, CD45RA+CD62L+, CD45RO-CD27+CD95low and HLA-DR+CD38+ was assessed using three-color flow cytometric analysis of whole blood. Thymic index score was based on computed tomographic scans of the thymus. The relationship of TREC with thymic index and the expression of the naive phenotypes was evaluated. RESULTS: TREC expression was not statistically different in these HIV-positive patients from that in age-matched HIV-negative controls. Among HIV-positive patients with CD4 cell count of > 500 x 10(6) cells/l after antiretroviral therapy (n = 15), PBMC TREC levels correlated with the expression of CD45RA+CD45RO- and CD45RA+CD62L+ naive phenotypes, and inversely correlated with the expression of HLA-DR+CD38+. The change between pre- and post-therapy CD4 cell counts for these 15 patients significantly correlated with both thymic index and expression of the CD45RA+CD45RO- phenotype. CONCLUSIONS: The finding that TREC expression was equivalent between HIV-positive patients after therapy and HIV-negative donors suggests that there is no reduction in thymic output among HIV-positive individuals after therapy. Given that TREC is inversely correlated with HLA-DR/CD38 expression, its analysis in studies of thymopoiesis should be evaluated in the context of maximum viral suppression to reduce HIV-mediated immune activation and/or by normalizing for cell turnover.
BACKGROUND: The adult human thymus contributes to de novo T cell synthesis; such synthesis can be assessed by analyzing T cell receptor excision circles (TREC). METHODS: TREC levels were measured in total peripheral blood mononuclear cells (PBMC) and CD4- and CD8-enriched cells of 29 HIV-positivepatients with maximal viral suppression. The expression of CD45RA+CD45RO-, CD45RA+CD62L+, CD45RO-CD27+CD95low and HLA-DR+CD38+ was assessed using three-color flow cytometric analysis of whole blood. Thymic index score was based on computed tomographic scans of the thymus. The relationship of TREC with thymic index and the expression of the naive phenotypes was evaluated. RESULTS: TREC expression was not statistically different in these HIV-positivepatients from that in age-matched HIV-negative controls. Among HIV-positivepatients with CD4 cell count of > 500 x 10(6) cells/l after antiretroviral therapy (n = 15), PBMC TREC levels correlated with the expression of CD45RA+CD45RO- and CD45RA+CD62L+ naive phenotypes, and inversely correlated with the expression of HLA-DR+CD38+. The change between pre- and post-therapy CD4 cell counts for these 15 patients significantly correlated with both thymic index and expression of the CD45RA+CD45RO- phenotype. CONCLUSIONS: The finding that TREC expression was equivalent between HIV-positivepatients after therapy and HIV-negative donors suggests that there is no reduction in thymic output among HIV-positive individuals after therapy. Given that TREC is inversely correlated with HLA-DR/CD38 expression, its analysis in studies of thymopoiesis should be evaluated in the context of maximum viral suppression to reduce HIV-mediated immune activation and/or by normalizing for cell turnover.
Authors: D Chadwick; J Pido-Lopez; A Pires; N Imami; F Gotch; J S Villacian; S Ravindran; N I Paton Journal: Clin Exp Immunol Date: 2003-12 Impact factor: 4.330
Authors: Pratip K Chattopadhyay; Daniel C Douek; Stephen J Gange; Karen R Chadwick; Marc Hellerstein; Joseph B Margolick Journal: AIDS Res Hum Retroviruses Date: 2006-06 Impact factor: 2.205
Authors: Ryan D Kilpatrick; Tammy Rickabaugh; Lance E Hultin; Patricia Hultin; Mary Ann Hausner; Roger Detels; John Phair; Beth D Jamieson Journal: J Immunol Date: 2008-02-01 Impact factor: 5.422
Authors: Thao Pham; Marvin Belzer; Joseph A Church; Christina Kitchen; Craig M Wilson; Steven D Douglas; Yongzhi Geng; Monica Silva; Richard M Mitchell; Paul Krogstad Journal: Clin Diagn Lab Immunol Date: 2003-03
Authors: Donald L Sodora; Jeffrey M Milush; Felecia Ware; Aneta Wozniakowski; Lisa Montgomery; Harold M McClure; Andrew A Lackner; Marta Marthas; Vanessa Hirsch; R Paul Johnson; Daniel C Douek; Richard A Koup Journal: J Virol Date: 2002-10 Impact factor: 5.103
Authors: Ven Natarajan; Richard A Lempicki; Irini Sereti; Yunden Badralmaa; Joseph W Adelsberger; Julia A Metcalf; Darue A Prieto; Randy Stevens; Michael W Baseler; Joseph A Kovacs; H Clifford Lane Journal: Proc Natl Acad Sci U S A Date: 2002-07-29 Impact factor: 11.205
Authors: Alan Landay; Lorie Benning; James Bremer; Barbara Weiser; Harold Burger; Marek Nowicki; Andrea Kovacs Journal: J Infect Dis Date: 2003-07-01 Impact factor: 5.226
Authors: Richardson Fleuridor; Brian Wilson; Runhua Hou; Alan Landay; Harold Kessler; Lena Al-Harthi Journal: Immunology Date: 2003-01 Impact factor: 7.397